← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Allegheny-Singer Research Institute
Pittsburgh, PA
$59,500,877
Total funding
55
Grants
Funding over time
peak $4.8M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$58,844,828 · 51
NSF$656,049 · 2
SAMHSA$0 · 2
By mechanism
R01$45,023,208 · 26
R21$4,265,579 · 10
UH3$2,276,454 · 1
K08$1,815,881 · 3
R00$1,178,557 · 1
N01$927,638 · 2
Investigators at Allegheny-Singer Research Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
Anti-inflammatory Small Drug as Adjunctive Therapy to Improve Glucometabolic Variables in Obese, Insulin-Resistant Type 2 Diabetic Patients$1,163,411
UH3 · FY2015 · TR
Anti-inflammatory Small Drug as Adjunctive Therapy to Improve Glucometabolic Variables in Obese, Insulin-Resistant Type 2 Diabetic Patients$1,113,043
UH3 · FY2016 · TR
THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEA$1,015,183
R01 · FY2002 · DC
THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEA$986,426
R01 · FY2001 · DC
THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEA$961,999
R01 · FY2000 · DC
The Role of Biofilms in the Pathogenesis of Otorrhea$818,770
R01 · FY2008 · DC
The Role of Biofilms in the Pathogenesis of Otorrhea$809,222
R01 · FY2007 · DC
The Role of Biofilms in the Pathogenesis of Otorrhea$809,117
R01 · FY2006 · DC
The Role of Biofilms in the Pathogenesis of Otorrhea$804,456
R01 · FY2005 · DC
Role of Biofilms in the Pathogenesis of Otorrhea$793,525
R01 · FY2004 · DC
PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension$749,226
R01 · FY2017 · HL
PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension$694,555
R01 · FY2018 · HL
Pneumococcal Biofilms in Otitis Media$678,843
R01 · FY2005 · DC
PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension$656,406
R01 · FY2019 · HL
Impact of Antibiotics and Vaccines on the in vivo Evolution of S. pneumoniae$639,377
R01 · FY2010 · AI
Impact of Antibiotics and Vaccines on the in vivo Evolution of S. pneumoniae$639,377
R01 · FY2009 · AI
Pneumococcal Biofilms in Otitis Media$586,221
R01 · FY2003 · DC
Pneumococcal Biofilms in Otitis Media$568,797
R01 · FY2006 · DC
Pneumococcal Biofilms in Otitis Media$564,087
R01 · FY2007 · DC
Pneumococcal Biofilms in Otitis Media$550,403
R01 · FY2004 · DC